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Abstract
The neuronal function of Cys-loop neurotransmitter receptors is established; however, their role in non-neuronal cells is poorly defined. As brain tumors accumulate the neurotransmitter glycine, we studied expression and function of glycine receptors (GlyR) in glioma cells. Human brain tumor biopsies selectively expressed GlyR subunits with nuclear import signal (NLS, α 1 and α 3). The mouse glioma cell line GL261 expressed GlyR α 1, and knock-down of α 1 protein expression impaired self-renewal capacity and tumorigenicity of GL261 glioma cells as evidenced by the neurosphere assay and GL261
cell inoculation in vivo, respectively. We furthermore show that the pronounced tumorigenic effect of GlyR α 1 relies on a new intracellular signaling function that depends on the NLS region in the large cytosolic loop and impacts on GL261 glioma cell gene regulation. Stable expression of GlyR α 1 and α 3 loops rescued self-renewal capacity of GlyR α 1 knock-down cells, which demonstrates their functional equivalence. The new
Introduction
Glycine receptors (GlyRs) belong to the Cys-loop neurotransmitter receptor family of ligand-gated ion channels. Members of this receptor family share a common protein architecture with an extracellular ligand binding domain, four transmembrane segments and a large cytosolic loop domain between transmembrane segments 3 and 4. Four genes (Glra1-4) coding for GlyR α1-4 subunits have been identified, and each of these subunits is able to produce functional homomeric glycine-gated Cl -channels (Harvey et al., 2000; Kuhse et al., 1991; Malosio et al., 1991; Nikolic et al., 1998) . In humans, however, GLRA4 is a pseudo gene (Simon et al., 2004) . A single gene (Glrb) delivers cells with the GlyR β subunit, which mediates postsynaptic receptor anchoring (Meier et al., 2001; Meyer et al., 1995) and can contribute to glycine binding (Grudzinska et al., 2005) , but is unable to produce functional homo-pentameric GlyR channels. GlyR α1 and α3 structurally differ from α2, α4 or β subunits as they contain a functional nuclear import signal (NLS) in the large cytosolic loop domain (Melzer et al., 2010) . Although it is established that the NLS interacts with nuclear import proteins of the karyopherin family (importin α3 and α4) (Melzer et al., 2010) , the functional role of this sequence determinant remained elusive. It was suggested to play a role in non-neuronal cells (den Eynden et al., 2009 ). Brain tumors are enriched with the neurotransmitter glycine (Bobek-Billewicz et al., 2010) , which raises the question as to whether glioma cell-GlyRs serve a classical neurotransmitter receptor function or use their NLS for intracellular signaling.
Here, we addressed this question and discovered that the NLS-harboring GlyR α1 and α3 subunits were expressed in human brain tumor biopsies. We found that glioma cellGlyRs were retained in intracellular compartments and did not serve as neurotransmitter receptors. To study the functional role of intracellular GlyR expression in glioma cells, we used the mouse glioma cell line GL261, which specifically expressed the GlyR α1ins
RNA splice variant (Malosio et al., 1991) with hitherto unknown function. Knock-down of GlyR α1ins protein expression impaired tumorigenicity and self-renewal capacity. The pronounced anti-tumor effect of reduced GlyR α 1ins protein expression relies on an intracellular GlyR signaling function and involves the large cytosolic loop domain including the GlyR-intrinsic NLS in tumor cell gene regulation, including proto-
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oncogenes, molecules involved in signaling pathways of extracellular-signal-regulated kinase ERK and β -catenin/Wnt, transcription factors, and a plethora of stemnessdetermining gene products as GlyR target genes. That self-renewal capacity of GlyR α 1ins knock-down GL261 cells was rescued upon stable expression of α 1ins and α 3K
loops furthermore demonstrates functional equivalence of both GlyR subunits in brain tumor cells.

Results
GlyR α1 and α3 are expressed in human brain tumor biopsies and stem cells
To study GlyR expression in human glioma biopsies, quantitative real-time PCR analysis of GlyR α1, α2, and α3-coding mRNA was performed on a β-actin normalized cDNA panel of pathologist-verified human brain tumors (Suppl. Table 1 ). We did not include the α4 subunit into our analyses because this type of GlyR will not form functional glycine-gated receptor channels at the cell surface due to a premature STOP codon encoded by the human GLRA4 gene (Simon et al., 2004) . Following amplification of the samples, PCR products were analyzed with agarose gel electrophoresis, and a sample was only included into our quantitative expression analysis if a single band with the correct molecular weight was detected. GLRA1 gene expression was detected primarily in WHO grade II and III tumors, while GLRA3 gene expression was more widespread and found throughout WHO grade I-IV tumors ( Fig. 1 , Suppl. Table 1 ). GlyR α2 mRNA was not detected (except case #36).
We next analyzed expression of GlyR α1 and α3 subunits in established and well characterized human stem-like glioma cells (Galan-Moya et al., 2011; Silvestre et al., 2011; Thirant et al., 2011 ) (Suppl. Table 2 ). Messenger RNA coding for the GlyR α1ins
RNA splice variant (Malosio et al., 1991) was detected in 3 out of 6 stem-like cell samples from adult oligoastrocytoma and glioblastoma multiforme (Galan-Moya et al., 2011; Silvestre et al., 2011) , while GlyR α1 mRNA in stem-like cells from pediatric glioma (Thirant et al., 2011) lacked the RNA splice insert (Suppl. Table 2 ). GlyR α3-coding mRNA was detected in all the analyzed samples (Suppl. Table 2 ). Moreover, the vast majority (9 out of 11) of stem-like cells expressed the GlyR α3K RNA splice variant (Nikolic et al., 1998) , which sets this cell type apart from neurons with regard to preponderant expression of the long GlyR α3L RNA splice variant in neurons (Eichler et al., 2009 ).
Characteristics of GlyR expression in mouse GL261 glioma cells
We used here the EGFP-expressing mouse cell line GL261 (Walzlein et al., 2008) which is commonly used for the generation of experimental brain tumors in mice. GL261 cells selectively expressed mRNA coding only for the GlyR α1ins RNA splice variant Journal of Cell Science Accepted manuscript (Malosio et al., 1991) , not for α2, α3, α4, or β subunits ( Fig. 2A) . To confirm that GlyR α1ins-coding mRNA results in expression of receptor protein, we used a polyclonal GlyR α1-directed antibody for immunochemical analysis of GL261 cells (Fig. 2B ). Strong GlyR α1 protein expression was found in 10 ± 5 % of GL261 cells. We verified that polyclonal GlyR α1 antibody-dependent signals were specific as evidenced by the congruency of immunochemical signals generated in combination with the well characterized GlyR α1-specific mAb2b antibody (Fig. 2C) . The GlyR α1-positive cells showed morphological peculiarities such as a spherical shape and reduced adherence (Fig. 2B, C ). More strikingly, GlyR α1 protein was detected mainly in cytosol and nucleus of GL261 cells (Fig. 2B , high-power view right hand, arrows, Suppl. Table 3 ),
suggesting that GlyRs do not serve as neurotransmitter receptors in these cells.
Consistently with the nuclear localization of GlyR α1, GL261 cells expressed importin α 3 and α 4 ( Fig. 2D ) which mediate nuclear import of GlyRs (Melzer et al., 2010) .
GlyRs do not form glycine-gated ion channels at the surface of GL261 or human glioma cells
We used the patch-clamp technique to record membrane currents in response to glycine application. To monitor changes in membrane conductance, the membrane potential was repetitively clamped to a series of hyper-and de-polarizing potentials ranging from -120 to +20 mV, as described earlier for the recording of GABA A R-dependent Cl -currents (Labrakakis et al., 1998) . GlyR α1-positive, round shaped and slightly detached GL261 cells were investigated (Fig. 3A) , but the membrane conductance was not affected by glycine application (Fig. 3B , C; n = 15). Likewise, human glioma cells from resected glioblastoma multiforme did not respond to glycine application (TU7/00, Suppl. Fig. 1A , Fig. 3C ; n = 15), despite expression of GlyR α1-and α3-coding mRNA in these cells (Suppl. Fig. 1B-D) . GlyR α 2-coding mRNA was not detected (Suppl. Fig. 1D ), while GlyR α 4-and β -coding mRNAs were found to be expresseed (Suppl. Fig. 1E ). However, these GlyR subunits will not form functional neurotransmitter receptors at the cell surface of human cells. Thus, despite expression of various ligand-binding α-subunits, which are principally able to generate surface neurotransmitter receptors in human cells, GlyRs do not fulfill this task in mouse or human glioma cells (Fig. 3C) . Furthermore, we found that importin α 3 and α 4 were expressed in the majority of samples derived from glioblastoma multiforme (Suppl. Fig. 1E ), suggesting that GlyR subunits with nuclear import signals (NLS, α 1 and α 3) exert an intranuclear function in mouse and human glioma cells.
Full-length GlyR α1ins is expressed in intracellular compartments of glioma cells
Ubiquitin-dependent proteolytic processing of GlyR α1ins was shown to release receptor fragments with molecular weights of 35 and 13 kDa, the latter corresponding to the size of large cytosolic loop including transmembrane domain (TM) 4 (Büttner et al., 2001 ).
Hence, we next investigated whether proteolysis is responsible for intracellular GlyR expression in glioma cells (Fig. 4) . To this end, we generated a recombinant GlyR α1ins Table 3) . For control purpose, we verified that the recombinant GlyRs were able to access the cell surface in HEK293 cells (Fig. 4D ). These results show that full-length GlyR α1ins is retained in intracellular compartments of glioma cells including the nucleus (Suppl. Table 3 ).
GlyR α1 ("myc-α1ins-NLS-ΔLL-α2-HA", Figure 5A ) was not sufficient for receptor surface expression (Fig. 5C ). However, GlyR α1ins was detected at the cell surface and disappeared from the nucleus upon additional disruption of the NLS ("myc-α1ins-ΔLL-ΔNLS-α2-HA", Fig. 5A , D, Suppl. Table 3 ), suggesting that the NLS is responsible for the restriction of GlyR α1ins to the intracellular compartment of GL261 cells.
To investigate whether intracellular GlyR expression in GL261 is subunit-specific or valid for all α -subunits with NLS, we transfected GL261 cells with a mCherry-GlyR α 3K
fusion construct and performed 3D confocal live cell receptor imaging to furthermore gather information about the dynamics of intracellular receptor distribution (Suppl. . Table 3 ), the live cell imaging also revealed that α3K clusters are highly mobile and rapidly shuttle back and forth between cytosol and nucleus ( Fig. 6B ; arrow, 00:14-00:16 min, and arrowheads, 00:19-00:20 min; Suppl. Fig. 2B ). Intra-nuclear dynamics however were much slower, and α3K clusters remained associated for several minutes with different euchromatin regions (Fig. 6B, arrow) . Just like GlyR α 1ins (above, Fig. 4C ), mCherryGlyR α3K clusters were thus detected at the same time at different euchromatin positions in the GL261 cell nucleus, suggesting that they may influence transcription of different genes. For control purpose, we verified that mCherry-GlyR α3K accessed the surface of HEK293 cells by recording glycine-dependent transmembrane Cl -currents (Suppl. Fig.   3 ). Collectively, these results show that the NLS in the large cytosolic loops of full-length α1ins-and α3K-GlyRs come into play specifically in glioma cells and mediate cytosolic and intra-nuclear receptor expression.
Knock-down of GlyR expression changes GL261 gene expression
To study functional relevance of intracellular GlyR expression, GlyR α1ins expression was knocked-down in GL261 cells. Stable knock-down cell lines were obtained by transfection of GL261 cells with GlyR α1-specific small hairpin RNA constructs 'G10'
and 'G11' (Fig. 7A ). Our immunochemical analyses confirmed the small hairpin RNAdependent impact on GlyR α1 protein expression because ubiquitin-associated perinuclear GlyR α1 immunoreactivity was detected in G10 and G11 cells ( Fig. 7B ; 'α1-KD-1' and 'α1-KD-2'). Consistently, the western blot analyses revealed that full-length GlyR α1ins protein expression was reduced to 36.3% ± 1.8 in α1-KD-1 and 13.4% ± 0.8 in α1-KD-2 cells (means ± SD, n = 3 experiments) compared to the expression level in control GL261 cells (100%). Western blot against the house keeping protein α-tubulin served as reference for normalization purpose (Fig. 7C, D) . To find out whether intra- (Eomes, Eef1a1, Gata4, Isl1, Olig2, Pax6) and factors that determine stemness (Bxdc2, Cd9, Dnmt3b, Gata6, Gdf3, Il6st, Kit, Ifitm2, Nes, Tert) was down-regulated in the two GlyR knock-down cell lines. Just a few gene products were up-regulated (Gcg, Pax4, Tdgf1; Fig. 7E , Suppl. Table 4 ). These results show that intracellular GlyRs change expression of genes with tumorigenic potential.
Knock-down of GlyR expression impairs neurosphere formation
To address the possibility that the GlyR-dependent impact on GL261 gene expression affects GL261 cell self-renewal capacity, we applied the limiting dilution assay, which is an independent predictor of clinical outcome in malignant glioma (Laks et al., 2009) . To this end, the different GL261 cell lines were cultured in stem cell medium until first neurospheres appeared. Then, the minimal number of cells required for neurosphere formation in each well of the culture dish was determined (Fig. 8) 
Knock-down of GlyR expression impairs glioma formation in vivo
In order to find out whether impaired self-renewal capacity would result in reduced tumorigenicity, GL261, α1-KD-1, and α1-KD-2 cells were inoculated by stereotactic injection into the caudate putamen of GL261-congenic wild-type mice (Fig. 8E) , and the probability of survival and life span of GL261 cell-inoculated mice were monitored ( tumor formation was significantly prolonged, which suggests that glioma formation was slowed down in those animals that developed tumors despite knock-down of GlyR expression (Fig. 8F) . Consistently, post-mortem analysis revealed similarly sized tumors in all animals which died due to GL261 cell inoculation (Suppl. Fig. 4A -C), but with a significant delay in the experimental mouse groups that were inoculated with GlyR knock-down cells (Fig. 8F ). Thus, our conclusion is, supported by reduced proliferation rates of α1-KD-1 and α1-KD-2 cell lines in cell culture (Suppl. Fig. 4D ), that knock- Bxdc2, Cd9, Dnmt3b, Gata6, Gdf3, Il6st, Kit, Ifitm2, Nes, Tert) and are good candidates for the genes responsible for impaired self-renewal capacity of α 1-KD-1 and α 1-KD-2 cells in the neurosphere formation assay and impairment of GlyR α 1ins knock-down GL261 cells to initiate glioma formation in the experimental mouse model. Although the exact signaling mechanisms of the GlyR-dependent impact on GL261 gene expression remain to be determined, our study identifies an intriguing strategic (possibly gene regulatory) role for the NLS-harboring large cytoplasmic loop domain of GlyRs in glioma cells. That both GlyR α 1ins and α 3K large cytosolic loop domains were able to rescue self-renewal capacity of GlyR α 1ins knock-down GL261 cells furthermore demonstrates functional equivalence of this GlyR protein region encoded by exon 9. In fact, the large cytosolic loops of GlyR α 1ins and α 3K share 60% sequence homology (Combet et al., 2000) . Thus, the identified GlyR protein regions and their consensus sequence may be relevant for tumor therapy as they could be functionally neutralized using cell-penetrating peptides that specifically target glioma cells through proteolytic activation (Jiang et al., 2004) in patients with GlyR α 1-and/or α 3-positive brain tumors.
In summary, our study determines a non-charged amino acid sequence environment of the NLS in GlyR α1ins and α3K large cytosolic loops as glioma cell-specific and tumorigenic intracellular GlyR signaling domain. These results make a strategic contribution to the field by revealing a new intracellular and gene regulatory GlyR function that goes much beyond the protein's well established role as neuronal Cys-loop neurotransmitter receptor.
Materials and methods
Analysis of resected brain tumors was performed according to the rules laid down by the Ethical Committee (Charité, EA4-098-11), and informed consent was obtained according to the Declaration of Helsinki (BMJ 1991; 302: 1194 
GlyR expression constructs
Recombinant GlyR α1ins and α2B expression constructs with surface accessible myc and intracellular HA epitope tags were generated using site-directed mutagenesis, following the GeneEditor protocol (Promega, Mannheim, Germany). The myc tag was inserted between the second and third amino acid of the mature, signal peptide cleaved, receptor proteins. The mCherry-GlyR α3K construct for confocal live cell imaging was obtained likewise by inserting a BspE1 restriction site at this position and in frame cloning of mCherry-coding sequence. To generate GlyR mCherry-α1ins-TM3-4 and mCherry-α3K-TM3-4 loop constructs for the production of Zeocin-resistant stable cell lines, standard molecular cloning procedures were used for their cloning into the pTRACER vector (Clontech). In fusion constructs, the loop domains started with "VSK" and ended with "ISR" followed by linker "GPVAT" (α1ins) or "PVAT" (α3K) and the mCherry-coding sequence. In addition, because GL261 cells already express EGFP, the EGFP-coding sequence in the Zeocin resistance cassette was excised using fusion-PCR. 30 mM sucrose, 10 mM HEPES, 0.25 mM L-glutamine, 230 µM sodium-pyruvate, 100 U/ml penicillin, and 100 µg/ml streptomycin at 37°C / 5% CO2, as described previously (Labrakakis et al., 1998) . The EGFP-expressing high-grade astrocytoma cell line GL261 [(Walzlein et al., 2008) , isogenic to C57BL/6 mice; National Cancer Institute, Frederick, MD] was used throughout and cultured as aforementioned or in stem cell medium (2% B27, 100 U/ml penicillin, 100 µg/ml streptomycin, 20 ng/ml FGF-2, 20 ng/ml EGF in DMEM supplemented with F-12 (Invitrogen Life Technologies)).
Transfection of GL261 cells was carried out using Amaxa Nucleofector system (kit V, program V001; Lonza, Basel, Switzerland). GlyR α1 knock-down cell lines were obtained by electroporation of 3 to 5x10 6 GL261 cells with 2 µg DNA of small hairpin (sh) RNA expression constructs directed against GlyR α1 (TRC6-G10 and TRC6-G11) or containing scrambled shRNA sequences (Open Biosystems, Huntsville, AL USA) for control purpose. To select and maintain stable shRNA-expressing GL261 cells 0.8 µg/µl puromycine was added to culture medium. Two stable GlyR α1 knock-down cell lines were obtained with shRNAs TRC6-G10 and TRC6-G11 and will throughout be referred to as α1-KD-1 and α1-KD-2. Stable α1-KD-2 cell lines expressing mCherry, mCherry- Human embryonic kidney cells (HEK293) were cultured as described above and transfected using a standard Ca 2+ /phosphate protocol. Two to three days after transfection cells were processed for electrophysiology, immunochemistry or live cell imaging.
Neurosphere formation in the limiting dilution assay
For the limiting dilution assay, cells were cultured in stem cell medium until primary sphere formation was noted. Cells were then dissociated and plated in 96-well plates in 0.2 ml volumes of stem cell medium. Final cell dilutions ranged from 2000 cells/well to 10 cells/well in 0.2 ml volumes. Twelve wells were seeded per cell plating density.
Cultures were fed 0.025 ml of stem cell medium every 2 days until day 7, when the percentage of wells not containing spheres for each cell plating density was calculated and plotted against the number of cells per well. Regression analysis was performed to extract X-intercept values, which represent the number of cells required to form at least 1 neurosphere in every well.
Inoculation of GL261 cells into the mouse brain
Female wild-type C57Bl/6 mice were purchased from Charles River Laboratories (Sulzfeld, Germany) or bred at the local animal facility. Mouse GL261 control or GlyR α1 knock-down cells (α1-KD-1 and α1-KD-2) were suspended in Earle's MEM supplemented with Vitamin B12 (0.25 µM) and B27 Supplement (20 µl/ml; both Invitrogen), and 1 µl of cell suspension (2*10 4 cells/µl) was injected into the caudate putamen region (1 mm anterior and 1.5 mm lateral to bregma, as described earlier (Glass et al., 2005) .
Electrophysiology
For patch clamp experiments extracellular and intracellular solutions as described previously (Labrakakis et al., 1998) were used. Briefly, extracellular solution contained Cells were clamped at -50 mV, and current-voltage (I-V) relations were obtained from voltage ramps from −100 mV to +100 mV with a duration of 400 ms applied every 5 seconds. Traces were recorded with a List EPC7 amplifier and Patchmaster software.
Data were sampled at 10 kHz and filtered online at 2.83 kHz (10 kHz + 3 kHz Bessel).
HEK cells (500.000) were seeded onto 35 mm dishes 3 days before, and transfected 1 day before measurement with 2 µg plasmid DNA (containing either mCherry-GlyRα3K) and
Fugene HD® (Promega, Mannheim, Germany) according to the manufacturer's instructions. 1-5 hrs prior to the recording, transfected HEK293 cells were split 1:6 onto glass cover slips and identified according to mCherry fluorescence which was acquired under a 40X objective using a 16-bit cooled CCD camera (Spot PURSUIT, Visitron Systems GmbH, Puchheim, Germany).
RNA isolation, cDNA synthesis and PCR
RNA was isolated from cultured cells using TRIzol Reagent (Invitrogen). cDNA of mouse GL261 glioma cells was screened as described above, except that oligonucleotides specific to mouse GlyR α1 (5'-CTGTTTGCCTGCTCTTCGTGT-3' and 5'-TGGGGAAACCGATGCGAGATA-3'), α2 (5'-ACCGAGTGAATATTTTTCT GAGAC-3' and 5'-GTGAAACTTGACCTCAATGCAG-3'), α3 were included, and again, the ratio between GlyR α-and GAPDH-specific oligonucleotides was adjusted to 15:1 (α1 and α2) and 20:1 (α3).. Thirty-five cycles (1 minute annealing at 54°C and 1 minute elongation at 72°C) were run. For the purpose of control of oligonucleotides and the PCR protocol, adult mouse hippocampus RNA was processed accordingly.
Quantitative real-time PCR, human brain cancer tissue and mouse stem cell pluripotency array
A β-actin normalized cDNA panel of pathologist-verified human brain tumors (OriGene Technologies, Inc., Rockville, MD, USA) was used to probe for GLRA1, GLRA2, and
GLRA3 gene transcript levels by quantitative real-time PCR. The following TaqMan
Gene Expression Assays (Applied Biosystems, Foster City, CA, USA) were used:
GLRA1_Hs00609267_m1, GLRA2_Hs01033736_m1, and GLRA3_Hs00197920_m1.
Quantitative real-time PCR was performed according to the TaqMan Gene Expression
Assay protocol using the iCycler IQ 5 multicolor real-time detection system (Bio-Rad, Munich, Germany). cDNAs obtained from GL261 control or GlyR α1 knock-down cells (α1-KD-1 and α1-KD-2) were analysed in a TaqMan Mouse Stem Cell Pluripotency Array (Invitrogen #4414080) using a 7500 real time PCR system with SDS Software and TaqMan universal PCR master mix (Applied Biosystems, Foster City, CA, USA)
according to the manufacturer's instructions. Data were acquired for 40 cycles (cut-off).
Western blot
Western blot was performed for verification of GlyR protein expression in GL261 cells 
Immunocytochemistry
For analysis of GL261-endogenous GlyR α1 protein, cells were fixed for 10 minutes at -20°C with a mixture (95:5) of methanol and glacial acetic acid and then processed for immunocytochemistry with a rabbit polyclonal antibody (1:300, Abcam, Cambridge, MA, USA) or the well-characterised mouse mAb2b antibody (1:100, Synaptic Systems).
For detection of surface accessible myc tag, the mouse monoclonal 9E10 antibody
(1:100, Sigma) was used. For this purpose, the 9E10 antibody was applied directly to the cell culture and incubated for the duration of 10 minutes at 37°C in incubator, washed 3 times with culture medium, fixed as described before and then processed for immunocytochemistry using the rat monoclonal 3F10 antibody (1:200, Roche Applied Science, Mannheim, Germany). Ubiquitin immunoreactivity was assessed using a polyclonal antibody (UB N-19) made in goat (1:100, Santa Cruz Biotechnology Inc., Heidelberg, Germany). Following 3 wash steps, affinity-purified secondary donkey antibodies coupled to carboxymethyl indocyanine (Cy5) or fluorescein isothiocyanate (FITC) were used. The secondary antibodies were purchased from Jackson
ImmunoResearch Laboratories (West Grove, PA, USA).
Microscopy and live cell imaging
Fluorescent signals were acquired using the laser-scanning confocal microscope DM TCS SP5 (Leica Microsystems). Fluorochromes were excited sequentially to minimize crosstalk between fluorescent signals. Fluorescence was acquired using a HCX PL APO 40.0x
UV oil objective (Leica Microsystems). Images were acquired using LCS software (Leica Microsystems) by multiple scanning and averaging of lines (8 times each). Live cell
imaging with confocal microscopy was performed likewise, except that multiple scanning was reduced to 3 frames per image. Cell nuclei and GlyR α3K were visualized using Hoechst 33342 (Invitrogen) and mCherry fluorescence, respectively. Optical sections were obtained along the Z-axis using 1 µm step size. Frames were acquired every minute.
Movies were created using the software Imaris x64 7.6 (Bitplane Scientific Software, Zurich, Switzerland) and exported at a frame rate of 10 per second. For quantification of nuclear versus somatic GlyR distributions, integrated signal intensities were measured cell-wise within circular regions of interest (10 µm diameter) which were nucleuscentered and placed in the perinuclear cytoplasm as described (Winkelmann et al., 2014) .
Statistics
Statistical analysis of tumor cell-inoculated mice (Kaplan-Meier-survival-analysis, 
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